SCHEMBL12809477

SCHEMBL12809477

CCc1cc(C(C)(C)C)cc(CCN2CCOCC2)c1OC

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.45
CYP2D6 P10635 2/20 0.41
CYP3A4 P08684 1/20 0.41
PKM P14618 1/20 0.41
SYK P43405 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPK14 Q16539 3/20 0.39
HTR6 P50406 1/20 0.39
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
POLB P06746 1/20 0.38
SCARB1 Q8WTV0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13843836 0.87 CYP2D6 (0.50) SIGMAR1CYP2D6CYP3A4PKMSYK
SCHEMBL13843680 0.84 SIGMAR1 (0.42) SIGMAR1CYP2D6CYP3A4PKMSYK
SCHEMBL14999487 0.77 PTGS2 (0.39) CYP2D6L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL10104440 0.75 CYP2A13 (0.47) CYP2D6CYP3A4PKMSYKSMN1; SMN2
SCHEMBL5124007 0.73 SMN1; SMN2 (0.40) SIGMAR1CYP2D6CYP3A4L3MBTL1SMN1; SMN2
SCHEMBL13130492 0.71 MAPT (0.45) SMN1; SMN2MEN1KMT2ANPSR1TSHR
SCHEMBL5124004 0.71 HCRTR1 (0.42) MAPK14ALDH1A1SMN1; SMN2KDM4E
SCHEMBL12781734 0.70 CYP2D6 (0.67) SIGMAR1CYP2D6CYP3A4SYKL3MBTL1
SCHEMBL14999406 0.70 PTGS2 (0.33) L3MBTL1SMN1; SMN2
SCHEMBL12781742 0.69 CYP2D6 (0.62) SIGMAR1CYP2D6CYP3A4SYKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1692116-B1 1,2,3-TRIAZOLE AMIDE DERIVATIVES AS INHIBITORS OF CYTOKINE PRODUCTION BOEHRINGER INGELHEIM PHARMA (US) 2011-03-09 EP disclosed